Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03403803 · ClinicalTrials.gov registry record
Prognosis and Therapeutic Biomarkers for Glioblastoma Patients
A clinical trial, sponsored by Baylor Research Institute.
- Terminated
- Registry status
- 10
- Enrollment target
NCT03403803 is a clinical trial that was terminated before completion, run by Baylor Research Institute. The registered enrollment target is 10 participants.
The verdict
NCT03403803 was terminated before completion, sponsored by Baylor Research Institute.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate if the potential biomarkers identified could be used for facilitating the diagnosis and prognosis of patients with glioblastoma (GBM).
Interventions
- DEVICE Optune
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2019-03-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03403803
The ClinicalTrials.gov registry entry for NCT03403803 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Optune is the first listed.
NCT03403803 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03403803 about?
NCT03403803 is a clinical study titled "Prognosis and Therapeutic Biomarkers for Glioblastoma Patients". The purpose of this study is to investigate if the potential biomarkers identified could be used for facilitating the diagnosis and prognosis of patients with glioblastoma (GBM).
What is the current status of trial NCT03403803?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2017-09-01. Estimated completion is 2019-03-25.
What interventions are being tested in trial NCT03403803?
The interventions under investigation include: Optune (DEVICE).
Who is sponsoring clinical trial NCT03403803?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.